MedTrace Logo

Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort

NCT04097704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2020-05-21

No results posted yet for this study

Summary

This is a multi-center observational follow-up study to collect saliva samples that allow pharmacogenetic analysis of the subjects that participated in the CC-90007-CP-003 study.

Approximately 28 subjects with moderate and severe hepatic impairment and healthy control subjects with normal hepatic function will be enrolled.

Conditions

  • Hepatic Insufficiency

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • Leon Carayannopoulos, MD · Celgene Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097704 on ClinicalTrials.gov